Thurston Springer Miller Herd & Titak Inc. Makes New $45,000 Investment in Cardinal Health, Inc. (NYSE:CAH)

Thurston Springer Miller Herd & Titak Inc. purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 461 shares of the company’s stock, valued at approximately $45,000.

Several other institutional investors and hedge funds also recently made changes to their positions in CAH. Acadian Asset Management LLC boosted its position in shares of Cardinal Health by 19.1% during the first quarter. Acadian Asset Management LLC now owns 3,723,159 shares of the company’s stock worth $416,585,000 after buying an additional 598,002 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in shares of Cardinal Health by 0.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,730,854 shares of the company’s stock valued at $305,584,000 after purchasing an additional 14,030 shares during the last quarter. Norges Bank bought a new stake in shares of Cardinal Health in the fourth quarter worth $258,499,000. California Public Employees Retirement System boosted its holdings in Cardinal Health by 118.9% during the fourth quarter. California Public Employees Retirement System now owns 1,516,035 shares of the company’s stock worth $152,816,000 after purchasing an additional 823,520 shares during the last quarter. Finally, Brandes Investment Partners LP grew its position in Cardinal Health by 2.4% in the fourth quarter. Brandes Investment Partners LP now owns 1,221,191 shares of the company’s stock valued at $123,096,000 after purchasing an additional 28,042 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analyst Weigh In

CAH has been the topic of a number of recent research reports. Evercore ISI lowered their target price on Cardinal Health from $115.00 to $105.00 and set an “in-line” rating on the stock in a research report on Tuesday, July 9th. Robert W. Baird upped their price objective on Cardinal Health from $129.00 to $130.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 9th. StockNews.com raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Citigroup lowered their target price on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating on the stock in a report on Friday, July 19th. Finally, Argus cut their price target on shares of Cardinal Health from $120.00 to $115.00 and set a “buy” rating for the company in a research note on Wednesday, May 15th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and an average target price of $109.67.

Cardinal Health Price Performance

CAH stock traded up $1.01 during midday trading on Wednesday, reaching $100.53. 204,112 shares of the stock were exchanged, compared to its average volume of 2,138,231. The stock has a market capitalization of $24.49 billion, a PE ratio of 44.23, a P/E/G ratio of 1.14 and a beta of 0.61. Cardinal Health, Inc. has a 52 week low of $85.11 and a 52 week high of $116.04. The company has a fifty day moving average price of $98.57 and a 200 day moving average price of $103.32.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.